nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CALM1—type 2 diabetes mellitus	0.355	1	CbGaD
Promethazine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0273	0.0759	CbGbCtD
Promethazine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0262	0.0727	CbGbCtD
Promethazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0252	0.0699	CbGbCtD
Promethazine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0218	0.0605	CbGbCtD
Promethazine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.02	0.0555	CbGbCtD
Promethazine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0194	0.0539	CbGbCtD
Promethazine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0183	0.0508	CbGbCtD
Promethazine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.017	0.0472	CbGbCtD
Promethazine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0145	0.0402	CbGbCtD
Promethazine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0145	0.0402	CbGbCtD
Promethazine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.014	0.039	CbGbCtD
Promethazine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0133	0.0371	CbGbCtD
Promethazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0132	0.0367	CbGbCtD
Promethazine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0129	0.0358	CbGbCtD
Promethazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0122	0.0339	CbGbCtD
Promethazine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0118	0.0327	CbGbCtD
Promethazine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.011	0.0304	CbGbCtD
Promethazine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0105	0.0292	CbGbCtD
Promethazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.01	0.0278	CbGbCtD
Promethazine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00964	0.0268	CbGbCtD
Promethazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0096	0.0267	CbGbCtD
Promethazine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0074	0.0206	CbGbCtD
Promethazine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00718	0.0199	CbGbCtD
Promethazine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00677	0.0188	CbGbCtD
Promethazine—ABCB1—Losartan—type 2 diabetes mellitus	0.00657	0.0182	CbGbCtD
Promethazine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00283	0.0684	CbGeAlD
Promethazine—HTR2A—arteriole—type 2 diabetes mellitus	0.00271	0.0654	CbGeAlD
Promethazine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.0019	0.046	CbGeAlD
Promethazine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00172	0.0417	CbGeAlD
Promethazine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.00138	0.0333	CbGeAlD
Promethazine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.00137	0.0332	CbGeAlD
Promethazine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00116	0.028	CbGeAlD
Promethazine—CALM2—artery—type 2 diabetes mellitus	0.00108	0.0262	CbGeAlD
Promethazine—CALM1—artery—type 2 diabetes mellitus	0.00108	0.0261	CbGeAlD
Promethazine—CALM2—nerve—type 2 diabetes mellitus	0.00108	0.026	CbGeAlD
Promethazine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00107	0.0259	CbGeAlD
Promethazine—CALM1—nerve—type 2 diabetes mellitus	0.00107	0.0259	CbGeAlD
Promethazine—DRD2—nerve—type 2 diabetes mellitus	0.000989	0.0239	CbGeAlD
Promethazine—CALM2—endothelium—type 2 diabetes mellitus	0.000916	0.0221	CbGeAlD
Promethazine—CALM1—endothelium—type 2 diabetes mellitus	0.000911	0.022	CbGeAlD
Promethazine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000836	0.0202	CbGeAlD
Promethazine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000663	0.016	CbGeAlD
Promethazine—HTR2A—artery—type 2 diabetes mellitus	0.000657	0.0159	CbGeAlD
Promethazine—HTR2A—nerve—type 2 diabetes mellitus	0.000652	0.0157	CbGeAlD
Promethazine—CALM3—retina—type 2 diabetes mellitus	0.000567	0.0137	CbGeAlD
Promethazine—HTR2A—endothelium—type 2 diabetes mellitus	0.000555	0.0134	CbGeAlD
Promethazine—CALM3—nephron tubule—type 2 diabetes mellitus	0.000534	0.0129	CbGeAlD
Promethazine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000521	0.0126	CbGeAlD
Promethazine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000518	0.0125	CbGeAlD
Promethazine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000472	0.0114	CbGeAlD
Promethazine—CALM3—pancreas—type 2 diabetes mellitus	0.000466	0.0113	CbGeAlD
Promethazine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000457	0.011	CbGeAlD
Promethazine—CALM2—retina—type 2 diabetes mellitus	0.000445	0.0108	CbGeAlD
Promethazine—CALM1—retina—type 2 diabetes mellitus	0.000443	0.0107	CbGeAlD
Promethazine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.00043	0.0104	CbGeAlD
Promethazine—CALM3—adipose tissue—type 2 diabetes mellitus	0.000423	0.0102	CbGeAlD
Promethazine—CALM2—nephron tubule—type 2 diabetes mellitus	0.000419	0.0101	CbGeAlD
Promethazine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000417	0.0101	CbGeAlD
Promethazine—DRD2—retina—type 2 diabetes mellitus	0.000409	0.00989	CbGeAlD
Promethazine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000377	0.0091	CbGeAlD
Promethazine—CHRM3—kidney—type 2 diabetes mellitus	0.000377	0.00909	CbGeAlD
Promethazine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000375	0.00906	CbGeAlD
Promethazine—CALM2—kidney—type 2 diabetes mellitus	0.000369	0.0089	CbGeAlD
Promethazine—CALM1—kidney—type 2 diabetes mellitus	0.000367	0.00886	CbGeAlD
Promethazine—CALM2—pancreas—type 2 diabetes mellitus	0.000366	0.00884	CbGeAlD
Promethazine—CALM1—pancreas—type 2 diabetes mellitus	0.000364	0.0088	CbGeAlD
Promethazine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000359	0.00867	CbGeAlD
Promethazine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000357	0.00863	CbGeAlD
Promethazine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000353	0.00853	CbGeAlD
Promethazine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000339	0.0082	CbGeAlD
Promethazine—CALM2—adipose tissue—type 2 diabetes mellitus	0.000332	0.00802	CbGeAlD
Promethazine—CALM1—adipose tissue—type 2 diabetes mellitus	0.000331	0.00799	CbGeAlD
Promethazine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000312	0.00753	CbGeAlD
Promethazine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000312	0.00753	CbGeAlD
Promethazine—CALM3—liver—type 2 diabetes mellitus	0.000297	0.00717	CbGeAlD
Promethazine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.00028	0.00676	CbGeAlD
Promethazine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000277	0.0067	CbGeAlD
Promethazine—CYP2B6—kidney—type 2 diabetes mellitus	0.000274	0.00662	CbGeAlD
Promethazine—HTR2A—retina—type 2 diabetes mellitus	0.00027	0.00652	CbGeAlD
Promethazine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000241	0.00583	CbGeAlD
Promethazine—CALM2—liver—type 2 diabetes mellitus	0.000233	0.00563	CbGeAlD
Promethazine—CALM1—liver—type 2 diabetes mellitus	0.000232	0.0056	CbGeAlD
Promethazine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000228	0.00552	CbGeAlD
Promethazine—HTR2A—kidney—type 2 diabetes mellitus	0.000224	0.0054	CbGeAlD
Promethazine—ADRA1A—liver—type 2 diabetes mellitus	0.000219	0.00528	CbGeAlD
Promethazine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000207	0.005	CbGeAlD
Promethazine—CYP2D6—kidney—type 2 diabetes mellitus	0.000204	0.00492	CbGeAlD
Promethazine—ABCB1—retina—type 2 diabetes mellitus	0.000177	0.00427	CbGeAlD
Promethazine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000175	0.00139	CcSEcCtD
Promethazine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000174	0.00138	CcSEcCtD
Promethazine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00137	CcSEcCtD
Promethazine—CYP2B6—liver—type 2 diabetes mellitus	0.000173	0.00418	CbGeAlD
Promethazine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000173	0.00137	CcSEcCtD
Promethazine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000172	0.00136	CcSEcCtD
Promethazine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000172	0.00136	CcSEcCtD
Promethazine—CYP2C9—liver—type 2 diabetes mellitus	0.000172	0.00414	CbGeAlD
Promethazine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00136	CcSEcCtD
Promethazine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00017	0.00134	CcSEcCtD
Promethazine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00017	0.00134	CcSEcCtD
Promethazine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000169	0.00133	CcSEcCtD
Promethazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Promethazine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Promethazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Promethazine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Promethazine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Promethazine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Promethazine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000167	0.00133	CcSEcCtD
Promethazine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000167	0.00403	CbGeAlD
Promethazine—Erythema—Metformin—type 2 diabetes mellitus	0.000166	0.00131	CcSEcCtD
Promethazine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000166	0.00131	CcSEcCtD
Promethazine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000165	0.00131	CcSEcCtD
Promethazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000165	0.00131	CcSEcCtD
Promethazine—Syncope—Valsartan—type 2 diabetes mellitus	0.000163	0.00129	CcSEcCtD
Promethazine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000163	0.00129	CcSEcCtD
Promethazine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00129	CcSEcCtD
Promethazine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000161	0.00127	CcSEcCtD
Promethazine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000161	0.00127	CcSEcCtD
Promethazine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000161	0.00127	CcSEcCtD
Promethazine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Promethazine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Promethazine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Promethazine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Promethazine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Promethazine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Promethazine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Promethazine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Promethazine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000157	0.00125	CcSEcCtD
Promethazine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000157	0.00124	CcSEcCtD
Promethazine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000157	0.00124	CcSEcCtD
Promethazine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Promethazine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Promethazine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Promethazine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000156	0.00123	CcSEcCtD
Promethazine—Tremor—Metformin—type 2 diabetes mellitus	0.000155	0.00123	CcSEcCtD
Promethazine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000155	0.00123	CcSEcCtD
Promethazine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000155	0.00122	CcSEcCtD
Promethazine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000154	0.00122	CcSEcCtD
Promethazine—Tension—Irbesartan—type 2 diabetes mellitus	0.000154	0.00122	CcSEcCtD
Promethazine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000153	0.00121	CcSEcCtD
Promethazine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000153	0.00121	CcSEcCtD
Promethazine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000152	0.0012	CcSEcCtD
Promethazine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000152	0.0012	CcSEcCtD
Promethazine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Promethazine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Promethazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000151	0.00119	CcSEcCtD
Promethazine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00015	0.00119	CcSEcCtD
Promethazine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00015	0.00119	CcSEcCtD
Promethazine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.00015	0.00362	CbGeAlD
Promethazine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Promethazine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Promethazine—Syncope—Metformin—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Promethazine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Promethazine—Oedema—Valsartan—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Promethazine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000148	0.00118	CcSEcCtD
Promethazine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000148	0.00117	CcSEcCtD
Promethazine—Rash—Glipizide—type 2 diabetes mellitus	0.000148	0.00117	CcSEcCtD
Promethazine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Promethazine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Promethazine—Erythema—Losartan—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Promethazine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000147	0.00116	CcSEcCtD
Promethazine—Oedema—Orlistat—type 2 diabetes mellitus	0.000147	0.00116	CcSEcCtD
Promethazine—Headache—Glipizide—type 2 diabetes mellitus	0.000147	0.00116	CcSEcCtD
Promethazine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000147	0.00116	CcSEcCtD
Promethazine—Palpitations—Metformin—type 2 diabetes mellitus	0.000147	0.00116	CcSEcCtD
Promethazine—ABCB1—kidney—type 2 diabetes mellitus	0.000146	0.00354	CbGeAlD
Promethazine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000146	0.00116	CcSEcCtD
Promethazine—Shock—Valsartan—type 2 diabetes mellitus	0.000146	0.00116	CcSEcCtD
Promethazine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000146	0.00115	CcSEcCtD
Promethazine—ABCB1—pancreas—type 2 diabetes mellitus	0.000145	0.00351	CbGeAlD
Promethazine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000145	0.00115	CcSEcCtD
Promethazine—Tension—Losartan—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Promethazine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Promethazine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Promethazine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Promethazine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Promethazine—Nervousness—Losartan—type 2 diabetes mellitus	0.000143	0.00113	CcSEcCtD
Promethazine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000143	0.00345	CbGeAlD
Promethazine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000142	0.00113	CcSEcCtD
Promethazine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000142	0.00112	CcSEcCtD
Promethazine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00112	CcSEcCtD
Promethazine—HTR2A—liver—type 2 diabetes mellitus	0.000141	0.00341	CbGeAlD
Promethazine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00014	0.00111	CcSEcCtD
Promethazine—Syncope—Irbesartan—type 2 diabetes mellitus	0.00014	0.00111	CcSEcCtD
Promethazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00014	0.00111	CcSEcCtD
Promethazine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Promethazine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Promethazine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Promethazine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Promethazine—Pain—Gliclazide—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Promethazine—Tremor—Losartan—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Promethazine—Rash—Glimepiride—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Promethazine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Promethazine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Promethazine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Promethazine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Promethazine—Headache—Glimepiride—type 2 diabetes mellitus	0.000137	0.00108	CcSEcCtD
Promethazine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Promethazine—Agitation—Losartan—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Promethazine—Oedema—Metformin—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Promethazine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Promethazine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000135	0.00107	CcSEcCtD
Promethazine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Promethazine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000133	0.00106	CcSEcCtD
Promethazine—Shock—Metformin—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Promethazine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Promethazine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Promethazine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000132	0.00105	CcSEcCtD
Promethazine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000132	0.00105	CcSEcCtD
Promethazine—Syncope—Losartan—type 2 diabetes mellitus	0.000132	0.00105	CcSEcCtD
Promethazine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000132	0.00319	CbGeAlD
Promethazine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Promethazine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Promethazine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Promethazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Promethazine—Palpitations—Losartan—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Promethazine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Promethazine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000129	0.00102	CcSEcCtD
Promethazine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000129	0.00102	CcSEcCtD
Promethazine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000129	0.00102	CcSEcCtD
Promethazine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000129	0.00102	CcSEcCtD
Promethazine—CYP2D6—liver—type 2 diabetes mellitus	0.000129	0.00311	CbGeAlD
Promethazine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000128	0.00101	CcSEcCtD
Promethazine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000128	0.00101	CcSEcCtD
Promethazine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000128	0.00101	CcSEcCtD
Promethazine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000128	0.00101	CcSEcCtD
Promethazine—Propericiazine—ADRA2A—type 2 diabetes mellitus	0.000128	0.0323	CrCbGaD
Promethazine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000127	0.00101	CcSEcCtD
Promethazine—Constipation—Valsartan—type 2 diabetes mellitus	0.000127	0.00101	CcSEcCtD
Promethazine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000127	0.001	CcSEcCtD
Promethazine—Hypotension—Metformin—type 2 diabetes mellitus	0.000126	0.001	CcSEcCtD
Promethazine—Erythema—Ramipril—type 2 diabetes mellitus	0.000126	0.001	CcSEcCtD
Promethazine—Shock—Irbesartan—type 2 diabetes mellitus	0.000126	0.000995	CcSEcCtD
Promethazine—Pain—Orlistat—type 2 diabetes mellitus	0.000126	0.000994	CcSEcCtD
Promethazine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000125	0.00099	CcSEcCtD
Promethazine—Anxiety—Losartan—type 2 diabetes mellitus	0.000125	0.000989	CcSEcCtD
Promethazine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000987	CcSEcCtD
Promethazine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000983	CcSEcCtD
Promethazine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000983	CcSEcCtD
Promethazine—Tension—Ramipril—type 2 diabetes mellitus	0.000124	0.000981	CcSEcCtD
Promethazine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000977	CcSEcCtD
Promethazine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000123	0.000976	CcSEcCtD
Promethazine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000123	0.000971	CcSEcCtD
Promethazine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000123	0.000971	CcSEcCtD
Promethazine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000121	0.000961	CcSEcCtD
Promethazine—Confusional state—Losartan—type 2 diabetes mellitus	0.000121	0.000959	CcSEcCtD
Promethazine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000121	0.000958	CcSEcCtD
Promethazine—Somnolence—Metformin—type 2 diabetes mellitus	0.00012	0.000952	CcSEcCtD
Promethazine—Trifluoperazine—CALM1—type 2 diabetes mellitus	0.00012	0.0304	CrCbGaD
Promethazine—Oedema—Losartan—type 2 diabetes mellitus	0.00012	0.000951	CcSEcCtD
Promethazine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00012	0.000951	CcSEcCtD
Promethazine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000119	0.000945	CcSEcCtD
Promethazine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000119	0.000943	CcSEcCtD
Promethazine—Perphenazine—CALM1—type 2 diabetes mellitus	0.000119	0.0301	CrCbGaD
Promethazine—Tremor—Ramipril—type 2 diabetes mellitus	0.000118	0.000936	CcSEcCtD
Promethazine—Shock—Losartan—type 2 diabetes mellitus	0.000118	0.000936	CcSEcCtD
Promethazine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000118	0.000932	CcSEcCtD
Promethazine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000118	0.000931	CcSEcCtD
Promethazine—Cyamemazine—HTR2C—type 2 diabetes mellitus	0.000117	0.0297	CrCbGaD
Promethazine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000117	0.000929	CcSEcCtD
Promethazine—Fatigue—Metformin—type 2 diabetes mellitus	0.000117	0.000924	CcSEcCtD
Promethazine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000116	0.000919	CcSEcCtD
Promethazine—Agitation—Ramipril—type 2 diabetes mellitus	0.000116	0.000919	CcSEcCtD
Promethazine—Constipation—Metformin—type 2 diabetes mellitus	0.000116	0.000916	CcSEcCtD
Promethazine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000114	0.000906	CcSEcCtD
Promethazine—Rash—Glyburide—type 2 diabetes mellitus	0.000114	0.000899	CcSEcCtD
Promethazine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000114	0.000899	CcSEcCtD
Promethazine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000113	0.000898	CcSEcCtD
Promethazine—Syncope—Ramipril—type 2 diabetes mellitus	0.000113	0.000896	CcSEcCtD
Promethazine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000113	0.000895	CcSEcCtD
Promethazine—Headache—Glyburide—type 2 diabetes mellitus	0.000113	0.000893	CcSEcCtD
Promethazine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000112	0.00089	CcSEcCtD
Promethazine—Hypotension—Losartan—type 2 diabetes mellitus	0.000112	0.000889	CcSEcCtD
Promethazine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000112	0.000883	CcSEcCtD
Promethazine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000111	0.000883	CcSEcCtD
Promethazine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000111	0.000879	CcSEcCtD
Promethazine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000111	0.000879	CcSEcCtD
Promethazine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000111	0.000876	CcSEcCtD
Promethazine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00011	0.000872	CcSEcCtD
Promethazine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000109	0.000866	CcSEcCtD
Promethazine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000109	0.000865	CcSEcCtD
Promethazine—Pain—Irbesartan—type 2 diabetes mellitus	0.000109	0.000865	CcSEcCtD
Promethazine—Metixene—HTR2C—type 2 diabetes mellitus	0.000109	0.0276	CrCbGaD
Promethazine—Insomnia—Losartan—type 2 diabetes mellitus	0.000109	0.00086	CcSEcCtD
Promethazine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000107	0.000848	CcSEcCtD
Promethazine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000107	0.000847	CcSEcCtD
Promethazine—Somnolence—Losartan—type 2 diabetes mellitus	0.000107	0.000846	CcSEcCtD
Promethazine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000107	0.000844	CcSEcCtD
Promethazine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000106	0.000837	CcSEcCtD
Promethazine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000105	0.000834	CcSEcCtD
Promethazine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000105	0.000833	CcSEcCtD
Promethazine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000105	0.000832	CcSEcCtD
Promethazine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000105	0.000832	CcSEcCtD
Promethazine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000104	0.000827	CcSEcCtD
Promethazine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000104	0.000823	CcSEcCtD
Promethazine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000104	0.000822	CcSEcCtD
Promethazine—Fatigue—Losartan—type 2 diabetes mellitus	0.000104	0.00082	CcSEcCtD
Promethazine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000103	0.000816	CcSEcCtD
Promethazine—Oedema—Ramipril—type 2 diabetes mellitus	0.000103	0.000816	CcSEcCtD
Promethazine—Pain—Losartan—type 2 diabetes mellitus	0.000103	0.000814	CcSEcCtD
Promethazine—Constipation—Losartan—type 2 diabetes mellitus	0.000103	0.000814	CcSEcCtD
Promethazine—Rash—Gliclazide—type 2 diabetes mellitus	0.000102	0.000807	CcSEcCtD
Promethazine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000102	0.000807	CcSEcCtD
Promethazine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000102	0.000805	CcSEcCtD
Promethazine—Shock—Ramipril—type 2 diabetes mellitus	0.000101	0.000803	CcSEcCtD
Promethazine—Headache—Gliclazide—type 2 diabetes mellitus	0.000101	0.000802	CcSEcCtD
Promethazine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000101	0.000799	CcSEcCtD
Promethazine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000101	0.000796	CcSEcCtD
Promethazine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.0001	0.000795	CcSEcCtD
Promethazine—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.9e-05	0.000784	CcSEcCtD
Promethazine—Dizziness—Valsartan—type 2 diabetes mellitus	9.83e-05	0.000778	CcSEcCtD
Promethazine—Dizziness—Orlistat—type 2 diabetes mellitus	9.71e-05	0.000769	CcSEcCtD
Promethazine—Asthenia—Metformin—type 2 diabetes mellitus	9.71e-05	0.000769	CcSEcCtD
Promethazine—Hypotension—Ramipril—type 2 diabetes mellitus	9.63e-05	0.000762	CcSEcCtD
Promethazine—Pruritus—Metformin—type 2 diabetes mellitus	9.57e-05	0.000758	CcSEcCtD
Promethazine—Chlorpromazine—CALM1—type 2 diabetes mellitus	9.44e-05	0.0239	CrCbGaD
Promethazine—Rash—Valsartan—type 2 diabetes mellitus	9.37e-05	0.000742	CcSEcCtD
Promethazine—Dermatitis—Valsartan—type 2 diabetes mellitus	9.36e-05	0.000741	CcSEcCtD
Promethazine—Insomnia—Ramipril—type 2 diabetes mellitus	9.32e-05	0.000738	CcSEcCtD
Promethazine—Headache—Valsartan—type 2 diabetes mellitus	9.31e-05	0.000737	CcSEcCtD
Promethazine—Diarrhoea—Metformin—type 2 diabetes mellitus	9.26e-05	0.000733	CcSEcCtD
Promethazine—ABCB1—liver—type 2 diabetes mellitus	9.26e-05	0.00224	CbGeAlD
Promethazine—Rash—Orlistat—type 2 diabetes mellitus	9.26e-05	0.000733	CcSEcCtD
Promethazine—Dermatitis—Orlistat—type 2 diabetes mellitus	9.25e-05	0.000732	CcSEcCtD
Promethazine—Headache—Orlistat—type 2 diabetes mellitus	9.2e-05	0.000728	CcSEcCtD
Promethazine—Asthenia—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000725	CcSEcCtD
Promethazine—Somnolence—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000725	CcSEcCtD
Promethazine—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000718	CcSEcCtD
Promethazine—Pruritus—Irbesartan—type 2 diabetes mellitus	9.03e-05	0.000715	CcSEcCtD
Promethazine—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.96e-05	0.000709	CcSEcCtD
Promethazine—Dizziness—Metformin—type 2 diabetes mellitus	8.95e-05	0.000708	CcSEcCtD
Promethazine—Fatigue—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000703	CcSEcCtD
Promethazine—Constipation—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000698	CcSEcCtD
Promethazine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000692	CcSEcCtD
Promethazine—Asthenia—Losartan—type 2 diabetes mellitus	8.62e-05	0.000683	CcSEcCtD
Promethazine—Rash—Metformin—type 2 diabetes mellitus	8.53e-05	0.000675	CcSEcCtD
Promethazine—Dermatitis—Metformin—type 2 diabetes mellitus	8.52e-05	0.000675	CcSEcCtD
Promethazine—Pruritus—Losartan—type 2 diabetes mellitus	8.5e-05	0.000673	CcSEcCtD
Promethazine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000672	CcSEcCtD
Promethazine—Headache—Metformin—type 2 diabetes mellitus	8.48e-05	0.000671	CcSEcCtD
Promethazine—Dizziness—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.000669	CcSEcCtD
Promethazine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	8.23e-05	0.0208	CrCbGaD
Promethazine—Diarrhoea—Losartan—type 2 diabetes mellitus	8.22e-05	0.000651	CcSEcCtD
Promethazine—Rash—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000637	CcSEcCtD
Promethazine—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000637	CcSEcCtD
Promethazine—Headache—Irbesartan—type 2 diabetes mellitus	8e-05	0.000633	CcSEcCtD
Promethazine—Dizziness—Losartan—type 2 diabetes mellitus	7.95e-05	0.000629	CcSEcCtD
Promethazine—Carbamazepine—ABCC2—type 2 diabetes mellitus	7.69e-05	0.0195	CrCbGaD
Promethazine—Rash—Losartan—type 2 diabetes mellitus	7.58e-05	0.0006	CcSEcCtD
Promethazine—Dermatitis—Losartan—type 2 diabetes mellitus	7.57e-05	0.000599	CcSEcCtD
Promethazine—Headache—Losartan—type 2 diabetes mellitus	7.53e-05	0.000596	CcSEcCtD
Promethazine—Asthenia—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000585	CcSEcCtD
Promethazine—Pruritus—Ramipril—type 2 diabetes mellitus	7.29e-05	0.000577	CcSEcCtD
Promethazine—Mesoridazine—HTR2C—type 2 diabetes mellitus	7.16e-05	0.0181	CrCbGaD
Promethazine—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000558	CcSEcCtD
Promethazine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	7.02e-05	0.0178	CrCbGaD
Promethazine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	6.93e-05	0.0175	CrCbGaD
Promethazine—Dizziness—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000539	CcSEcCtD
Promethazine—Rash—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000514	CcSEcCtD
Promethazine—Dermatitis—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000514	CcSEcCtD
Promethazine—Headache—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000511	CcSEcCtD
Promethazine—Clomipramine—ADRA2A—type 2 diabetes mellitus	6.23e-05	0.0158	CrCbGaD
Promethazine—Propiomazine—HTR2C—type 2 diabetes mellitus	6.03e-05	0.0153	CrCbGaD
Promethazine—Alimemazine—CYP3A4—type 2 diabetes mellitus	5.92e-05	0.015	CrCbGaD
Promethazine—Thioridazine—ADRA2A—type 2 diabetes mellitus	5.87e-05	0.0148	CrCbGaD
Promethazine—Clomipramine—HTR2C—type 2 diabetes mellitus	5.73e-05	0.0145	CrCbGaD
Promethazine—Trimipramine—ADRA2A—type 2 diabetes mellitus	5.73e-05	0.0145	CrCbGaD
Promethazine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	5.71e-05	0.0144	CrCbGaD
Promethazine—Methotrimeprazine—ADRA2A—type 2 diabetes mellitus	5.6e-05	0.0142	CrCbGaD
Promethazine—Pipotiazine—CYP1A2—type 2 diabetes mellitus	5.47e-05	0.0138	CrCbGaD
Promethazine—Doxepin—ADRA2A—type 2 diabetes mellitus	5.46e-05	0.0138	CrCbGaD
Promethazine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	5.45e-05	0.0138	CrCbGaD
Promethazine—Thioridazine—HTR2C—type 2 diabetes mellitus	5.4e-05	0.0137	CrCbGaD
Promethazine—Perphenazine—ADRA2A—type 2 diabetes mellitus	5.38e-05	0.0136	CrCbGaD
Promethazine—Trimipramine—HTR2C—type 2 diabetes mellitus	5.27e-05	0.0133	CrCbGaD
Promethazine—Methotrimeprazine—HTR2C—type 2 diabetes mellitus	5.16e-05	0.013	CrCbGaD
Promethazine—Carbamazepine—CYP1A2—type 2 diabetes mellitus	5.13e-05	0.013	CrCbGaD
Promethazine—Mequitazine—CYP3A4—type 2 diabetes mellitus	5.09e-05	0.0129	CrCbGaD
Promethazine—Doxepin—HTR2C—type 2 diabetes mellitus	5.03e-05	0.0127	CrCbGaD
Promethazine—Trifluoperazine—HTR2C—type 2 diabetes mellitus	5.01e-05	0.0127	CrCbGaD
Promethazine—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	4.99e-05	0.0126	CrCbGaD
Promethazine—Perphenazine—HTR2C—type 2 diabetes mellitus	4.96e-05	0.0125	CrCbGaD
Promethazine—Promazine—ADRA2A—type 2 diabetes mellitus	4.85e-05	0.0123	CrCbGaD
Promethazine—Desipramine—HTR2C—type 2 diabetes mellitus	4.61e-05	0.0117	CrCbGaD
Promethazine—Diltiazem—CYP3A4—type 2 diabetes mellitus	4.57e-05	0.0116	CrCbGaD
Promethazine—Promazine—HTR2C—type 2 diabetes mellitus	4.47e-05	0.0113	CrCbGaD
Promethazine—Oxcarbazepine—ALB—type 2 diabetes mellitus	4.35e-05	0.011	CrCbGaD
Promethazine—Clomipramine—CYP1A2—type 2 diabetes mellitus	4.33e-05	0.0109	CrCbGaD
Promethazine—Thioridazine—CYP2E1—type 2 diabetes mellitus	4.28e-05	0.0108	CrCbGaD
Promethazine—Chlorpromazine—ADRA2A—type 2 diabetes mellitus	4.27e-05	0.0108	CrCbGaD
Promethazine—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	4.26e-05	0.0108	CrCbGaD
Promethazine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	4.22e-05	0.0107	CrCbGaD
Promethazine—Methotrimeprazine—CYP2E1—type 2 diabetes mellitus	4.09e-05	0.0104	CrCbGaD
Promethazine—Thioridazine—CYP1A2—type 2 diabetes mellitus	4.07e-05	0.0103	CrCbGaD
Promethazine—Chlorpromazine—HTR2C—type 2 diabetes mellitus	3.93e-05	0.00995	CrCbGaD
Promethazine—Imipramine—HTR2C—type 2 diabetes mellitus	3.91e-05	0.0099	CrCbGaD
Promethazine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	3.91e-05	0.00989	CrCbGaD
Promethazine—Methotrimeprazine—CYP1A2—type 2 diabetes mellitus	3.89e-05	0.00985	CrCbGaD
Promethazine—Amitriptyline—HTR2C—type 2 diabetes mellitus	3.89e-05	0.00984	CrCbGaD
Promethazine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	3.89e-05	0.00983	CrCbGaD
Promethazine—Doxepin—CYP1A2—type 2 diabetes mellitus	3.79e-05	0.0096	CrCbGaD
Promethazine—Trifluoperazine—CYP1A2—type 2 diabetes mellitus	3.78e-05	0.00957	CrCbGaD
Promethazine—Methadone—CYP1A2—type 2 diabetes mellitus	3.77e-05	0.00955	CrCbGaD
Promethazine—Perphenazine—CYP1A2—type 2 diabetes mellitus	3.74e-05	0.00946	CrCbGaD
Promethazine—Desipramine—CYP2E1—type 2 diabetes mellitus	3.66e-05	0.00926	CrCbGaD
Promethazine—Pipotiazine—CYP3A4—type 2 diabetes mellitus	3.62e-05	0.00917	CrCbGaD
Promethazine—Desipramine—CYP1A2—type 2 diabetes mellitus	3.48e-05	0.00881	CrCbGaD
Promethazine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	3.46e-05	0.00876	CrCbGaD
Promethazine—Carbamazepine—CYP3A4—type 2 diabetes mellitus	3.4e-05	0.0086	CrCbGaD
Promethazine—Promazine—CYP1A2—type 2 diabetes mellitus	3.37e-05	0.00853	CrCbGaD
Promethazine—Acepromazine—ALB—type 2 diabetes mellitus	3.29e-05	0.00832	CrCbGaD
Promethazine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	3.23e-05	0.00817	CrCbGaD
Promethazine—Thioproperazine—ALB—type 2 diabetes mellitus	3.21e-05	0.00813	CrCbGaD
Promethazine—Pipotiazine—ALB—type 2 diabetes mellitus	3.16e-05	0.008	CrCbGaD
Promethazine—Chlorpromazine—CYP2E1—type 2 diabetes mellitus	3.12e-05	0.00789	CrCbGaD
Promethazine—Imipramine—CYP2E1—type 2 diabetes mellitus	3.1e-05	0.00785	CrCbGaD
Promethazine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	3.08e-05	0.0078	CrCbGaD
Promethazine—Chlorpromazine—CYP1A2—type 2 diabetes mellitus	2.97e-05	0.00751	CrCbGaD
Promethazine—Imipramine—CYP1A2—type 2 diabetes mellitus	2.95e-05	0.00747	CrCbGaD
Promethazine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	2.93e-05	0.00742	CrCbGaD
Promethazine—Clomipramine—CYP3A4—type 2 diabetes mellitus	2.86e-05	0.00725	CrCbGaD
Promethazine—Trimipramine—CYP3A4—type 2 diabetes mellitus	2.63e-05	0.00667	CrCbGaD
Promethazine—Doxepin—CYP3A4—type 2 diabetes mellitus	2.51e-05	0.00636	CrCbGaD
Promethazine—Clomipramine—ALB—type 2 diabetes mellitus	2.5e-05	0.00632	CrCbGaD
Promethazine—Methadone—CYP3A4—type 2 diabetes mellitus	2.5e-05	0.00632	CrCbGaD
Promethazine—Perphenazine—CYP3A4—type 2 diabetes mellitus	2.48e-05	0.00627	CrCbGaD
Promethazine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	2.45e-05	0.00619	CrCbGaD
Promethazine—Desipramine—CYP3A4—type 2 diabetes mellitus	2.3e-05	0.00583	CrCbGaD
Promethazine—Promazine—CYP3A4—type 2 diabetes mellitus	2.23e-05	0.00565	CrCbGaD
Promethazine—Chlorpromazine—CYP3A4—type 2 diabetes mellitus	1.96e-05	0.00497	CrCbGaD
Promethazine—Imipramine—CYP3A4—type 2 diabetes mellitus	1.95e-05	0.00495	CrCbGaD
Promethazine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	1.94e-05	0.00491	CrCbGaD
Promethazine—Chlorpromazine—ALB—type 2 diabetes mellitus	1.71e-05	0.00434	CrCbGaD
Promethazine—Amitriptyline—ALB—type 2 diabetes mellitus	1.69e-05	0.00429	CrCbGaD
Promethazine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—NOS3—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.75e-06	1.55e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.74e-06	1.54e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.74e-06	1.54e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—NFKB1—type 2 diabetes mellitus	1.74e-06	1.54e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—NFKB1—type 2 diabetes mellitus	1.74e-06	1.54e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.73e-06	1.53e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.73e-06	1.53e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—AKT1—type 2 diabetes mellitus	1.73e-06	1.53e-05	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—AKT1—type 2 diabetes mellitus	1.73e-06	1.53e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.73e-06	1.53e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.73e-06	1.53e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.72e-06	1.52e-05	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.72e-06	1.52e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.7e-06	1.51e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	1.69e-06	1.5e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.69e-06	1.49e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.69e-06	1.49e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.69e-06	1.49e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.69e-06	1.49e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.69e-06	1.49e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—SRC—type 2 diabetes mellitus	1.68e-06	1.48e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.68e-06	1.48e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	1.67e-06	1.48e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.67e-06	1.48e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.66e-06	1.47e-05	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.66e-06	1.47e-05	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.66e-06	1.47e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.66e-06	1.47e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.66e-06	1.46e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.66e-06	1.46e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.65e-06	1.46e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.65e-06	1.46e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.65e-06	1.46e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.65e-06	1.45e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	1.45e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.64e-06	1.45e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.64e-06	1.45e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.63e-06	1.44e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.63e-06	1.44e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—SRC—type 2 diabetes mellitus	1.62e-06	1.43e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—SRC—type 2 diabetes mellitus	1.62e-06	1.43e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.62e-06	1.43e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	1.62e-06	1.43e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.62e-06	1.43e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.62e-06	1.43e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.61e-06	1.43e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.61e-06	1.42e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	1.42e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.59e-06	1.4e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.59e-06	1.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.56e-06	1.38e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.56e-06	1.38e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.56e-06	1.38e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.56e-06	1.38e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.55e-06	1.37e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.55e-06	1.37e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	1.37e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	1.37e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—SRC—type 2 diabetes mellitus	1.55e-06	1.37e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.54e-06	1.36e-05	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.54e-06	1.36e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.53e-06	1.36e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.52e-06	1.34e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.51e-06	1.34e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.51e-06	1.34e-05	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.51e-06	1.34e-05	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.51e-06	1.33e-05	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.5e-06	1.33e-05	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.5e-06	1.32e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.5e-06	1.32e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—SRC—type 2 diabetes mellitus	1.5e-06	1.32e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—SRC—type 2 diabetes mellitus	1.5e-06	1.32e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.49e-06	1.32e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.49e-06	1.32e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.49e-06	1.31e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.49e-06	1.31e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.48e-06	1.31e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.48e-06	1.3e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.47e-06	1.3e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	1.47e-06	1.3e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.47e-06	1.3e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.46e-06	1.29e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.46e-06	1.29e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.46e-06	1.29e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.46e-06	1.29e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.45e-06	1.28e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.44e-06	1.27e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.44e-06	1.27e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.43e-06	1.26e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.42e-06	1.26e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	1.42e-06	1.26e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	1.42e-06	1.26e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.42e-06	1.25e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.42e-06	1.25e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.42e-06	1.25e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.42e-06	1.25e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.42e-06	1.25e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.41e-06	1.25e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.41e-06	1.25e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.41e-06	1.24e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.4e-06	1.24e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.4e-06	1.24e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.4e-06	1.23e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.4e-06	1.23e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.39e-06	1.23e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.39e-06	1.23e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.39e-06	1.23e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.39e-06	1.23e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.39e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	1.38e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.38e-06	1.22e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.38e-06	1.21e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.37e-06	1.21e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.37e-06	1.21e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.37e-06	1.21e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.37e-06	1.21e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.36e-06	1.2e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EGFR—type 2 diabetes mellitus	1.36e-06	1.2e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.35e-06	1.19e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.34e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	1.34e-06	1.18e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	1.34e-06	1.18e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.33e-06	1.18e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.33e-06	1.18e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.33e-06	1.17e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.33e-06	1.17e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.33e-06	1.17e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—type 2 diabetes mellitus	1.31e-06	1.16e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—type 2 diabetes mellitus	1.31e-06	1.16e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.31e-06	1.16e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.31e-06	1.15e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.3e-06	1.15e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.3e-06	1.15e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.3e-06	1.15e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.3e-06	1.15e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	1.14e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.29e-06	1.14e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.28e-06	1.13e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.28e-06	1.13e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.27e-06	1.12e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.27e-06	1.12e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.26e-06	1.12e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.26e-06	1.11e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.25e-06	1.11e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.25e-06	1.11e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	1.1e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.24e-06	1.1e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.24e-06	1.1e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.24e-06	1.1e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	1.1e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	1.1e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.24e-06	1.09e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	1.07e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.2e-06	1.06e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.2e-06	1.06e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.2e-06	1.06e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.19e-06	1.06e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.19e-06	1.06e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.19e-06	1.05e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.17e-06	1.04e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.17e-06	1.03e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-06	1.03e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.16e-06	1.03e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	1.03e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	1.02e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.15e-06	1.01e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.15e-06	1.01e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.14e-06	1.01e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.14e-06	1.01e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.14e-06	1.01e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.14e-06	1.01e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.14e-06	1.01e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.14e-06	1.01e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.14e-06	1e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.14e-06	1e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	1e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	1e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—type 2 diabetes mellitus	1.13e-06	9.97e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.12e-06	9.94e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.12e-06	9.94e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.12e-06	9.92e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.12e-06	9.89e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.1e-06	9.74e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.1e-06	9.74e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—type 2 diabetes mellitus	1.09e-06	9.65e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—type 2 diabetes mellitus	1.09e-06	9.65e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-06	9.57e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-06	9.32e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.05e-06	9.26e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.05e-06	9.26e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—type 2 diabetes mellitus	1.04e-06	9.21e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	1.04e-06	9.2e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.02e-06	9.02e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.02e-06	9.02e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—type 2 diabetes mellitus	1.01e-06	8.91e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—type 2 diabetes mellitus	1.01e-06	8.91e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	1.01e-06	8.9e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	1.01e-06	8.9e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.68e-07	8.56e-06	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	9.62e-07	8.5e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—type 2 diabetes mellitus	9.61e-07	8.49e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.5e-07	8.39e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.37e-07	8.28e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.37e-07	8.28e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—type 2 diabetes mellitus	9.3e-07	8.22e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—type 2 diabetes mellitus	9.3e-07	8.22e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.18e-07	8.11e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.18e-07	8.11e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.93e-07	7.89e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.79e-07	7.77e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.77e-07	7.75e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.74e-07	7.72e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.72e-07	7.7e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.63e-07	7.63e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.61e-07	7.6e-06	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	8.27e-07	7.31e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.24e-07	7.28e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.11e-07	7.16e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.09e-07	7.15e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.07e-07	7.13e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	8.05e-07	7.11e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.04e-07	7.1e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.96e-07	7.03e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.94e-07	7.02e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	7.79e-07	6.88e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	7.79e-07	6.88e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.3e-07	6.45e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.06e-07	6.24e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.06e-07	6.24e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.73e-07	5.95e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.51e-07	5.75e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.51e-07	5.75e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.1e-07	5.39e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.75e-07	5.08e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.7e-07	5.04e-06	CbGpPWpGaD
